99mTc-HIDA, a gallbladder imaging agent
โ Scribed by E. Chiotellis; C. Sawas-Dimopoulou; C. Koutoulidis; M. Constantinides
- Publisher
- Springer
- Year
- 1978
- Tongue
- English
- Weight
- 420 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
โฆ Synopsis
The molecule N-(2,6-dimethyl-phenyl-carbamoyl-methyl)-iminodiacetic acid (HIDA), capable of chelating reduced 99mTc, was synthesized, characterized, labeled with 99mTc, and studied in experimental animals. The results indicated that the new 99mTc-radiopharmaceutical is rapidly cleared from the blood to the liver, then rapidly removed to the gallbladder and excreted into the duodenum through the common bile duct. A comparative kinetic study of 99mTc-HIDA and 131I-Rose Bengal performed in rabbits demonstrated that both radiopharmaceuticals had a similar blood clearance rate, but cleared at a different rate from liver to gallbladder. 99mTc-HIDA showed a faster accumulation in the gallbladder than 131I-Rose Bengal. These findings, combined with the advantage of the low acute toxicity of HIDA, were promising enough to encourage a further evaluation and clinical investigation of this new Tc-99m hepatobiliary agent.
๐ SIMILAR VOLUMES
## Abstract Dimethylglyoxime (DMG) labelled with ^99m^Tc is here presented as a renal imaging agent. The behaviour of this complex was analysed at different pH by means of UV spectral data and using DMGโcalcium chloride as a reference complex. Biokinetic data were evaluated in two biological models
## Abstract Peptides are known as receptorโspecific molecules that play an important role not only in diagnosis and therapy of neoplastic diseases, but also in the pathogenesis of other diseases. In an effort to develop a peptideโbased radiopharmaceutical for scintigraphic studies, a small peptide